Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Gabby, as a neophyte at investing I confess to lacking

Jul 04, 2007 05:29PM

Jul 04, 2007 07:13PM

Jul 05, 2007 04:23AM

Jul 05, 2007 04:25AM

Jul 05, 2007 05:57AM

Jul 05, 2007 06:08AM

Jul 05, 2007 06:19AM

Jul 05, 2007 06:22AM

Jul 05, 2007 07:24AM

Jul 05, 2007 07:40AM

Jul 05, 2007 08:22AM

Jul 05, 2007 08:28AM

Gabby, as a neophyte at investing I confess to lacking

posted on Jul 05, 2007 08:43AM

a certain amount of expertise in the vagaries of the market. So I pose this question: Are there circumstances in which insiders are precluded from buying shares on the open market? Can they buy if they have knowledge of significant events not available to the investing public (that would be me)?

In too many cases I have seen the old "why aren't insiders buying if this company is so good" used as a red herring. Not saying you are doing so, but I also don't believe the fact that insiders are not buying is necessarily significant.  JMO


Jul 05, 2007 08:47AM

Jul 05, 2007 10:03AM

Jul 05, 2007 10:52AM

Jul 05, 2007 02:01PM
Share
New Message
Please login to post a reply